Barclays Maintains Overweight on Agilent Technologies, Raises Price Target to $195
10/7/2026
Impact: 70
Healthcare
Barclays analyst Luke Sergott has maintained an Overweight rating on Agilent Technologies (NYSE: A) and increased the price target from $175 to $195. This adjustment reflects a positive outlook for the company's performance.
AI summary, not financial advice
Share: